Significant savings in time over manual microscopy are possible through automating both acquisition steps and post processing of images to deliver data.
SAN JOSE, Calif. (PRWEB) February 27, 2018
Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of its ImageXpress® Pico Automated Cell Imaging System. Building on over 20 years of experience in the high content imaging space, this compact, affordable imaging system brings the power of both imaging and analysis to the individual lab bench.
As the pace of discovery continues to increase, researchers continue to look for tools such as the ImageXpress Pico system that help them to automate manual processes. “Significant savings in time over manual microscopy are possible through automating both acquisition steps and post processing of images to deliver data,” said Jeff McMillan, Senior Imaging Product Manager at Molecular Devices. “The system delivers improved efficiency in a single, easy-to-use software package.”
Combined with the latest edition of our CellReporterXpress Automated Image Acquisition and Analysis Software, the ImageXpress Pico system takes the guesswork out of setting up a range of assays by offering templates and simple, icon-driven tools to optimize parameters and produce reliable, repeatable data output.
“Over the past few years we have been continuing to invest in cellular imaging technology to bring a full suite of new tools to the research community,” said Greg Milosevich, President of Molecular Devices. “We’re excited to be able to continue to bring powerful tools within reach of every lab, supporting innovation in protein and cell biology.”
For more information, visit: http://www.moleculardevices.com/pico.
About Molecular Devices, LLC:
Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California with offices around the globe.